Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | CDKN2A |
Variant | W110fs |
Impact List | frameshift |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | CDKN2A W110fs results in a change in the amino acid sequence of the Cdkn2a protein beginning at aa 110 of 156, likely resulting in a premature truncation of the functional protein (UniProt.org). W110fs has not been characterized, however, due to the effects of a truncation mutation at the same site (PMID: 8668202), is predicted to lead to a loss of Cdkn2a protein function. |
Associated Drug Resistance | |
Category Variants Paths |
CDKN2A mutant CDKN2A inact mut CDKN2A W110fs |
Transcript | NM_000077.5 |
gDNA | chr9:g.(21971031_21971032) |
cDNA | c.(328_327) |
Protein | p.W110fs |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_058197.4 | chr9:g.(21974500_21974501) | c.(328_327) | p.W110fs | RefSeq | GRCh38/hg38 |
NM_058197.5 | chr9:g.(21974500_21974501) | c.(328_327) | p.W110fs | RefSeq | GRCh38/hg38 |
NM_000077 | chr9:g.(21971031_21971032) | c.(328_327) | p.W110fs | RefSeq | GRCh38/hg38 |
NM_058197 | chr9:g.(21974500_21974501) | c.(328_327) | p.W110fs | RefSeq | GRCh38/hg38 |
NM_000077.5 | chr9:g.(21971031_21971032) | c.(328_327) | p.W110fs | RefSeq | GRCh38/hg38 |
NM_001195132.2 | chr9:g.(21971031_21971032) | c.(328_327) | p.W110fs | RefSeq | GRCh38/hg38 |
XM_011517676 | chr9:g.(21971031_21971032) | c.(328_327) | p.W110fs | RefSeq | GRCh38/hg38 |
XM_011517675.3 | chr9:g.(21971031_21971032) | c.(328_327) | p.W110fs | RefSeq | GRCh38/hg38 |
NM_000077.4 | chr9:g.(21971031_21971032) | c.(328_327) | p.W110fs | RefSeq | GRCh38/hg38 |
XM_011517676.2 | chr9:g.(21971031_21971032) | c.(328_327) | p.W110fs | RefSeq | GRCh38/hg38 |
NM_001195132.1 | chr9:g.(21971031_21971032) | c.(328_327) | p.W110fs | RefSeq | GRCh38/hg38 |
XM_011517676.3 | chr9:g.(21971031_21971032) | c.(328_327) | p.W110fs | RefSeq | GRCh38/hg38 |
XM_011517675 | chr9:g.(21971031_21971032) | c.(328_327) | p.W110fs | RefSeq | GRCh38/hg38 |
XM_011517675.2 | chr9:g.(21971031_21971032) | c.(328_327) | p.W110fs | RefSeq | GRCh38/hg38 |
NM_001195132 | chr9:g.(21971031_21971032) | c.(328_327) | p.W110fs | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|